Understand the source comparison
Lipo-C Injection vs Oral Lipotropic Supplements: Bioavailability Comparison
Injectable Lipo-C (IM) 95–98% 92–96% 90–94% 30–45 minutes Direct delivery bypasses first-pass metabolism. Plasma concentrations reach therapeutic range within one hour, saturating methylation pathways simultaneously Oral tablet (fasted) 45–60% 40–55% 65–75% 90
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Injectable Lipo-C (IM)
- 95–98%
- 92–96%
- 90–94%
- 30–45 minutes
- Direct delivery bypasses first-pass metabolism. Plasma concentrations reach therapeutic range within one hour, saturating methylation pathways simultaneously
- Oral tablet (fasted)
- 45–60%
- 40–55%
- 65–75%
- 90–120 minutes
- Significant hepatic metabolism before systemic circulation. Peak plasma delayed and staggered across compounds, reducing synergistic effect
- Oral capsule (fed state)
- 30–45%
- 25–40%
- 50–65%
- 120–180 minutes
- Food interference compounds absorption losses. Methionine competes with other amino acids, choline absorption reduced by dietary fat content
- Sublingual lozenge
- 55–70%
- N/A (not formulated)
- 60–90 minutes
- Partial bypass of first-pass metabolism but inconsistent mucosal absorption. Salivary enzymes degrade methionine before absorption completes